Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using advanced MRI to evaluate facial nerves in parotid tumors

Official title: Application of 3D Magnetic Resonance Neurogram Sequences for Evaluation of Intraparotid Facial Nerves in Patients With Parotid Neoplasm

Run by Chinese University of Hong Kong · NCT05296109 · Data updated 2026-11-12

This study is testing if a new type of MRI can help doctors see facial nerves better during surgery for parotid tumors to reduce the risk of nerve damage.

More Parotid Neoplasms trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedFebruary 1, 2022
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedApril 3, 2026
Trial IDNCT05296109 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients diagnosed with parotid tumors who are eligible for MRI and can provide informed consent.

Probably not a fit

Patients with contraindications to MRI or those unable to cooperate during the scanning process may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to improve the evaluation of facial nerves during parotidectomy for patients with parotid neoplasms by utilizing high-resolution 3D MRI neurogram sequences. The researchers will recruit patients diagnosed with parotid tumors through other imaging methods and assess the efficacy of these advanced MRI techniques in visualizing the intra-parotid facial nerves. The goal is to reduce the risk of nerve injury during surgery, which can lead to temporary or permanent facial paralysis. The study will involve patients from an ear, nose, and throat specialty clinic who meet specific inclusion criteria.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of facial nerve injuries during parotid surgery.

How similar studies have gone: While traditional imaging has limitations, advancements in MRI techniques suggest potential for success, although this specific application may be novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Consecutive patients with parotid tumour diagnosed on other imaging modalities (such as ultrasonography or computed tomography), with or without cytological diagnosis from fine needle aspiration, will be recruited from the ear, nose and throat specialty clinic.

Exclusion Criteria:

* Patients who are contraindicated to magnetic resonance imaging (such as due to underlying MRI incompatible metallic implants)
* Patient who are contraindicated to MRI contrast agents (such as advanced renal failure or previous severe allergic reaction)
* Patients who cannot cooperate for MRI scanning.
* Patients show are unable to provide informed consent.

Where it's running

  • Gerald Choa MRI Center
    Hong Kong, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: Ho Sang Leung, MBBS (HK) — Department of Imaging and Interventional Radiology, Prince of Wales Hospital
  • Study coordinator: Gerald Choa MRI Center CUHK
  • Email: cumri@cuhk.edu.hk
  • Phone: 852-35051009

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.